Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-infectious Intermediate Uveitis”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Early research (Phase 1)Study completedNCT00280826
What this trial is testing

Efalizumab to Treat Uveitis

Who this might be right for
UveitisMacular Edema
National Eye Institute (NEI) 6
Large-scale testing (Phase 3)Looking for participantsNCT05486468
What this trial is testing

The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

Who this might be right for
UveitisUveitis, PosteriorUveitis, Anterior+1 more
Texas Retina Associates 30
Large-scale testing (Phase 3)Study completedNCT00404612
What this trial is testing

LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

Who this might be right for
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Lux Biosciences, Inc. 218
Large-scale testing (Phase 3)Study completedNCT00333814
What this trial is testing

The Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Who this might be right for
Intermediate UveitisPosterior Uveitis
Allergan 229
Post-approval studies (Phase 4)WithdrawnNCT05101928
What this trial is testing

Ozurdex Monotherapy Trial

Who this might be right for
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Ottawa Hospital Research Institute
Testing effectiveness (Phase 2)Study completedNCT00615693
What this trial is testing

Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis

Who this might be right for
UveitisPosterior UveitisPanuveitis
Novartis 13
Large-scale testing (Phase 3)Study completedNCT00404742
What this trial is testing

LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis

Who this might be right for
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Lux Biosciences, Inc. 232
Testing effectiveness (Phase 2)Study completedNCT01789320
What this trial is testing

Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis

Who this might be right for
UveitisIntermediate UveitisPosterior Uveitis+2 more
Clearside Biomedical, Inc. 11
Early research (Phase 1)Study completedNCT00078689
What this trial is testing

Daclizumab and Sirolimus to Treat Uveitis

Who this might be right for
Uveitis
National Eye Institute (NEI) 6
Large-scale testing (Phase 3)Ended earlyNCT01032915
What this trial is testing

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

Who this might be right for
Non-infectious Uveitis
Novartis Pharmaceuticals 125
Post-approval studies (Phase 4)UnknownNCT06085079
What this trial is testing

Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study

Who this might be right for
Uveitis, PosteriorUveitis, AnteriorUveitis, Intermediate+1 more
Massachusetts Eye Research and Surgery Institution 20
Not applicableStudy completedNCT01314469
What this trial is testing

Quality of Life in Patients With Intermediate Uveitis

Who this might be right for
Macular Edema
St. Franziskus Hospital
Not applicableStudy completedNCT03155243
What this trial is testing

Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice

Who this might be right for
Uveitis
AbbVie 155
Large-scale testing (Phase 3)WithdrawnNCT01103024
What this trial is testing

Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Who this might be right for
Uveitis
Novartis
Testing effectiveness (Phase 2)Ended earlyNCT05953688
What this trial is testing

POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Who this might be right for
Uveitis Posterior Non-InfectiousUveitis, IntermediateNoninfectious Panuveitis
Alumis Inc 36
Large-scale testing (Phase 3)Active Not RecruitingNCT06431373
What this trial is testing

Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Who this might be right for
Uveitis, PosteriorUveitis, IntermediateUveitis
Priovant Therapeutics, Inc. 371
Post-approval studies (Phase 4)Study completedNCT02764697
What this trial is testing

Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients

Who this might be right for
UveitisAnterior UveitisIntermediate Uveitis+3 more
Tampa Bay Uveitis Center, LLC 6
Testing effectiveness (Phase 2)Study completedNCT01526889
What this trial is testing

Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,

Who this might be right for
Non-infectious Intermediate UveitisNon-infectious Posterior UveitisNon-infectious Panuveitis
Novartis Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT00326508
What this trial is testing

Combination Daclizumab/Denileukin Diftitox to Treat Uveitis

Who this might be right for
Non-infectious Intermediate and Posterior Uveitis
National Eye Institute (NEI) 5
Early research (Phase 1)Study completedNCT00001526
What this trial is testing

ANTI-TAC THERAPY FOR UVEITIS

Who this might be right for
Uveitis
National Eye Institute (NEI) 15
Load More Results